Similar articles for PMID: 12549728

Year	Number of Results
1989	1
1992	1
1996	1
1997	1
1998	1
1999	6
2000	22
2001	19
2002	14
2003	14
2004	4
2005	4
2006	2
2009	1
2010	1
2011	3
2012	2
2015	2
2016	2
2026	0

1

Alosetron (Lotronex) is back: should I use it to treat my patients with irritable bowel syndrome?

Shen B, Soffer EE. Shen B, et al. Cleve Clin J Med. 2003 Jan;70(1):64-5. doi: 10.3949/ccjm.70.1.64. Cleve Clin J Med. 2003. PMID: 12549728 Free article. No abstract available.

2

Lotronex(tm): therapy for diarrhea predominant irritable bowel syndrome.

McGahan L. McGahan L. Issues Emerg Health Technol. 2000 Oct;(11):1-5. Issues Emerg Health Technol. 2000. PMID: 11902219 No abstract available.

3

Alosetron for irritable bowel syndrome.

Lièvre M. Lièvre M. BMJ. 2002 Sep 14;325(7364):555-6. doi: 10.1136/bmj.325.7364.555. BMJ. 2002. PMID: 12228116 Free PMC article. No abstract available.

4

Alosetron for irritable bowel syndrome. Senior vice president of GlaxoSmithKline responds.

Palmer JB. Palmer JB. BMJ. 2003 Jan 4;326(7379):51. BMJ. 2003. PMID: 12511473 No abstract available.

5

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.

Camilleri M, Chey WY, Mayer EA, Northcutt AR, Heath A, Dukes GE, McSorley D, Mangel AM. Camilleri M, et al. Arch Intern Med. 2001 Jul 23;161(14):1733-40. doi: 10.1001/archinte.161.14.1733. Arch Intern Med. 2001. PMID: 11485506 Clinical Trial.

6

Alosetron (Lotronex) for treatment of irritable bowel syndrome.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2000 Jun 26;42(1081):53-4. Med Lett Drugs Ther. 2000. PMID: 10872030 No abstract available.

7

Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.

Olden K, DeGarmo RG, Jhingran P, Bagby B, Decker C, Markowitz M, Carter E, Bobbitt W, Dahdul A, DeCastro E, Gringeri L, Johanson J, Levinson L, Mula G, Poleynard G, Stoltz RR, Truesdale R, Young D; Lotronex Investigator Team. Olden K, et al. Am J Gastroenterol. 2002 Dec;97(12):3139-46. doi: 10.1111/j.1572-0241.2002.07111.x. Am J Gastroenterol. 2002. PMID: 12492201 Clinical Trial.

8

FDA draws patients into alosetron risk management.

Miller JL. Miller JL. Am J Health Syst Pharm. 2000 Oct 1;57(19):1736. doi: 10.1093/ajhp/57.19.1736a. Am J Health Syst Pharm. 2000. PMID: 11030021 No abstract available.

9

FDA advisory panels recommend Lotronex be put back on market.

Charatan F. Charatan F. BMJ. 2002 May 4;324(7345):1053. doi: 10.1136/bmj.324.7345.1053/a. BMJ. 2002. PMID: 11993482 Free PMC article. No abstract available.

10

Contemporary thoughts on the treatment of irritable bowel syndrome.

Giaquinta D. Giaquinta D. Manag Care Interface. 2002 Aug;15(8):19-20, 22. Manag Care Interface. 2002. PMID: 12229060 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 12549728

100 results

Results by year